0001209191-22-051466.txt : 20220928 0001209191-22-051466.hdr.sgml : 20220928 20220928164751 ACCESSION NUMBER: 0001209191-22-051466 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220926 FILED AS OF DATE: 20220928 DATE AS OF CHANGE: 20220928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gandhi Mayank CENTRAL INDEX KEY: 0001832725 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39866 FILM NUMBER: 221276668 MAIL ADDRESS: STREET 1: 628 MIDDLEFIELD ROAD CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc. CENTRAL INDEX KEY: 0001828522 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853306396 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: (858) 925-8215 MAIL ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: Locust Walk Acquisition Corp. DATE OF NAME CHANGE: 20201015 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-26 0 0001828522 eFFECTOR Therapeutics, Inc. EFTR 0001832725 Gandhi Mayank C/O EFFECTOR THERAPEUTICS, INC. 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 0 1 0 0 Chief Business Officer Stock Option (Right to Buy) 0.565 2022-09-26 4 A 0 500000 0.00 A 2032-09-25 Common Stock 500000 500000 D The stock option vests 25% on September 26, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. /s/ Michael Byrnes, Attorney-in-Fact for Mayank Gandhi 2022-09-28